Additional Remarks on the Issue of Cancer Genomic Medicine-Focusing on Medical Insurance Issues

Research output: Contribution to journalArticlepeer-review

Abstract

Precision medicine, which provides personalized treatments based on individual genomic profiles, has made remarkable progress especially in the oncology area, since when 2 types of comprehensive genomic profiling(CGP)tests, FoundationOne CDx and OncoGuide NCC Oncopanel have been reimbursed by national insurance system in June 2019. However, the application of CGP as a companion diagnostics(CDx)in addition to the single and the multi-CDx tests is now complicated. In this session, problems of the personalized treatment system based on the results of the cancer genomic test will be discussed.

Original languageEnglish
Pages (from-to)1011-1013
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume49
Issue number9
Publication statusPublished - 2022 Sep 1

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Additional Remarks on the Issue of Cancer Genomic Medicine-Focusing on Medical Insurance Issues'. Together they form a unique fingerprint.

Cite this